Baird Medical Investment Holdings Limited
BDMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $194 | $81 | $64 | $71 |
| - Cash | $3 | $2 | $2 | $3 |
| + Debt | $21 | $10 | $7 | $3 |
| Enterprise Value | $212 | $90 | $70 | $71 |
| Revenue | $37 | $31 | $35 | $28 |
| % Growth | 17.7% | -10.4% | 26.6% | – |
| Gross Profit | $33 | $27 | $28 | $23 |
| % Margin | 88.2% | 86.6% | 79.9% | 83.6% |
| EBITDA | $16 | $13 | $16 | $14 |
| % Margin | 43.7% | 40.9% | 46.4% | 51.1% |
| Net Income | $12 | $11 | $13 | $12 |
| % Margin | 33.6% | 33.5% | 35.8% | 42.1% |
| EPS Diluted | 0.49 | 0.41 | 0.022 | -0.024 |
| % Growth | 19.5% | 1,789.4% | 189.7% | – |
| Operating Cash Flow | -$6 | -$1 | $0 | $5 |
| Capital Expenditures | -$3 | -$3 | -$6 | -$1 |
| Free Cash Flow | -$9 | -$4 | -$5 | $4 |